샘플 요청 목록

 카트 문의
시장보고서
상품코드
1874535

세계의 검체 유효성 시험 시장

Specimen Validity Testing
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 173 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 검체 유효성 시험 시장은 2030년까지 43억 달러에 달할 전망

세계의 검체 유효성 검사 시장은 2024년에 32억 달러로 추정되고 있으며, 2024-2030년의 분석 기간에 CAGR 5.0%로 성장하며, 2030년까지 43억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석 대상으로 한 부문의 하나인 검체 유효성 시험 제품은 4.4%의 CAGR을 기록하며, 분석 기간 종료까지 29억 달러에 달할 것으로 예측됩니다. 검체 유효성 시험 서비스 부문의 성장률은 분석 기간에 6.2%의 CAGR로 추정되고 있습니다.

미국 시장은 8억 6,680만 달러로 추정되며, 중국은 4.7%의 CAGR로 성장할 것으로 예측됩니다.

미국의 검체 유효성 검사 시장은 2024년에 8억 6,680만 달러로 추정되고 있습니다. 세계 2위의 경제대국인 중국은 2024-2030년의 분석 기간에 CAGR 4.7%로 추이하며, 2030년까지 6억 8,320만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장 분석으로는 일본과 캐나다를 들 수 있으며, 각각 분석 기간 중 CAGR 4.4%, 4.2%로 성장할 것으로 예측됩니다. 유럽에서는 독일이 약 3.8%의 CAGR로 성장할 것으로 예측됩니다.

세계 검체 유효성 검사 시장 - 주요 시장 동향과 촉진요인의 개요

약물 스크리닝에서 시료 유효성 검사가 필수적인 이유

검체 유효성 시험(SVT)은 검사 결과의 정확성, 신뢰성, 완전성을 보장하기 위해 약물 스크리닝 프로그램에서 점점 더 중요해지고 있습니다. 직장, 법 집행 기관, 스포츠 분야에서 약물 남용과 오남용이 심각한 문제로 대두되면서 시료의 변조, 혼입, 대체, 희석 등을 감지할 수 있는 강력한 약물 검사 기법의 필요성이 높아지고 있습니다. pH 검사, 비중 검사, 크레아티닌 수치 측정, 산화제 및 기타 위조 물질 검출 등을 포함한 검체 유효성 검사는 검사 결과 조작을 시도하는 행위를 식별하는 데 매우 중요한 역할을 합니다. 이를 통해 약물 검사 프로그램의 효과와 신뢰성을 유지하고, 공공의 안전, 조직의 규정 준수 및 직원의 건강을 보호할 수 있습니다.

기술 혁신은 검체 유효성 검사 시장을 어떻게 변화시키고 있는가?

검체 유효성 검사 방법, 장비, 시약의 기술적 발전은 약물 스크리닝 프로그램의 정확성, 속도, 신뢰성을 크게 향상시켰습니다. 통합형, 자동화, 신속 검사 플랫폼의 개발이 진행되면서 검사기관과 진료소가 검체 유효성 검사를 효율화하고 결과 보고까지 걸리는 시간을 단축할 수 있게 되었습니다. POC(Point of Care) 검사 장비, 원격 검사 솔루션, 디지털 데이터 관리 시스템의 혁신으로 검체 유효성 검사의 적용 범위는 기존 검사실 환경을 넘어 직장 검사, 원격의료, 현장 검사까지 확대되고 있습니다. 또한 효소 시약, 화학 시약 등 시약 구성의 발전으로 새로운 위조 물질 및 마스킹제의 검출 정확도가 향상되어 검체 유효성 검사 시장의 성장을 지원하고 있습니다.

시료 유효성 검사 산업의 성장을 주도하는 시장 부문은 무엇인가?

제품 유형에는 시약, 분석 키트, POC 장치, 검사 장비가 포함되며, 임상 실험실 및 법의학 실험실에서 광범위하게 사용되어 분석 키트가 가장 큰 시장 점유율을 차지하고 있습니다. 검사 유형은 pH, 비중, 크레아티닌, 산화제, 아질산염, 글루타르알데히드의 유효성 검사로 구성되어 있으며, 시료 변조 검출에 효과적인 pH 검사와 비중 검사가 주요 부문입니다. 최종 사용 분야는 임상 실험실, 법의학 연구소, 직장, 스포츠 단체, 법 집행 기관에 이르기까지 다양하며, 정확하고 신뢰할 수 있는 약물 검사에 대한 높은 수요로 인해 임상 실험실이 시장을 주도하고 있습니다. 지역적으로는 엄격한 규제 요건에 힘입어 북미와 유럽이 가장 큰 시료 유효성 검사 시장으로 부상하고 있습니다. 한편, 아시아태평양에서는 약물 검사 프로그램에 대한 인식과 채택이 증가함에 따라 급속한 성장이 예상됩니다.

검체 유효성 검사 시장의 성장을 이끄는 주요 요인은?

검체 유효성 검사 시장의 성장은 직장, 법 집행 기관, 임상 현장의 약물 검사 수요 증가, 검체 유효성 검사 방법 및 장비의 기술 발전, 약물 검사 프로그램의 정확성과 무결성 확보에 대한 관심 증가 등 여러 요인에 의해 촉진되고 있습니다. 약물 검사에서 변조, 혼입, 대체, 희석에 대한 검출 요구가 다양한 분야에서 시료 유효성 검사 솔루션에 대한 수요를 주도하고 있습니다. 통합, 자동화, 원격 검사 플랫폼의 기술 혁신과 더불어 시약 구성, POC(Point of Care) 기기, 디지털 데이터 관리의 발전은 검체 유효성 검사의 유효성, 속도 시장성을 향상시켜 시장 성장을 지원하고 있습니다. 의료, 스포츠, 정부, 군 분야에서 시료 유효성 검사의 적용이 확대되고 규제 준수, 표준화, 품질 보증에 대한 관심이 높아짐에 따라 시장 기업에게 새로운 기회가 창출되고 있습니다. 또한 다양한 환경에서의 비침습적, 휴대용, 디지털 방식의 유효성 검사 솔루션 개발에 초점을 맞추고 있는 것이 검체 유효성 검사 시장의 성장을 더욱 가속화하고 있습니다.

부문 :

제공(제품, 서비스), 유형(실험실 검사, 신속/POC 검사), 최종 용도(직장, 약물 스크리닝 연구소, 약물 재활 센터, 통증 관리 센터, 법집행기관, 기타 최종 용도)

조사 대상 기업의 예

  • Acm Global Laboratories
  • Alfa Scientific Designs, Inc.
  • Clinical Reference Laboratory, Inc.
  • Express Diagnostics Int'l, Inc.
  • Premier Brands of America, Inc.
  • Quest Diagnostics, Inc.
  • Sciteck, Inc.
  • Thermo Fisher Scientific, Inc.

AI 통합

검증된 전문가 컨텐츠와 AI 툴을 통해 시장 및 경쟁 정보 분석 방식을 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM(거대 언어 모델)이나 산업별 SLM(소규모 언어 모델)에 대한 쿼리 방식에 의존하는 대신, 전 세계 도메인 전문가들이 엄선한 컨텐츠 리포지토리를 구축했습니다. 여기에는 비디오 전사, 블로그, 검색엔진 조사, 그리고 방대한 양의 기업 데이터, 제품 및 서비스 데이터, 시장 데이터 등이 포함됩니다.

관세 영향 계수

이번 보고서에는 Global Industry Analysts가 예측한 본사 소재지, 생산기지, 수출입(완제품 및 OEM)에 따른 기업의 경쟁력 변화에 따라 지역 시장에 미치는 관세의 영향을 반영했습니다. 이러한 복잡하고 다면적인 시장 현실은 수입원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학을 통해 경쟁사들에게 영향을 미칠 것입니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 세계의 기타 지역

제4장 경쟁

KSA

Global Specimen Validity Testing Market to Reach US$4.3 Billion by 2030

The global market for Specimen Validity Testing estimated at US$3.2 Billion in the year 2024, is expected to reach US$4.3 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Specimen Validity Testing Products, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$2.9 Billion by the end of the analysis period. Growth in the Specimen Validity Testing Services segment is estimated at 6.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$866.8 Million While China is Forecast to Grow at 4.7% CAGR

The Specimen Validity Testing market in the U.S. is estimated at US$866.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$683.2 Million by the year 2030 trailing a CAGR of 4.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.4% and 4.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Specimen Validity Testing Market - Key Trends and Drivers Summarized

Why Is Specimen Validity Testing Becoming Essential in Drug Screening?

Specimen validity testing (SVT) is becoming increasingly essential in drug screening programs to ensure the accuracy, reliability, and integrity of test results. As drug abuse and misuse continue to pose significant challenges in workplaces, law enforcement, and sports, the need for robust drug screening methods that can detect tampering, adulteration, substitution, and dilution of specimens is on the rise. Specimen validity testing, which includes pH checks, specific gravity tests, creatinine levels, and the detection of oxidants and other adulterants, plays a crucial role in identifying attempts to manipulate test outcomes. This ensures that drug testing programs remain effective and credible, safeguarding public safety, organizational compliance, and employee health.

How Are Technological Advancements Shaping the Specimen Validity Testing Market?

Technological advancements in specimen validity testing methods, equipment, and reagents are significantly enhancing the accuracy, speed, and reliability of drug screening programs. The development of integrated, automated, and rapid testing platforms is gaining traction, enabling laboratories and clinics to streamline specimen validity testing and reduce turnaround times. Innovations in point-of-care (POC) testing devices, remote testing solutions, and digital data management systems are expanding the application scope of specimen validity testing beyond traditional laboratory settings to include workplace testing, remote healthcare, and field testing. Additionally, advancements in reagent formulations, such as enzymatic and chemical reagents, are improving the detection of newer adulterants and masking agents, supporting the growth of the specimen validity testing market.

Which Market Segments Are Leading the Growth of the Specimen Validity Testing Industry?

Product types include reagents, assay kits, POC devices, and testing instruments, with assay kits holding the largest market share due to their widespread use in clinical and forensic laboratories. Test types comprise validity tests for pH, specific gravity, creatinine, oxidants, nitrites, and glutaraldehyde, with pH and specific gravity tests being the dominant segments due to their effectiveness in detecting specimen tampering. End-use sectors span clinical laboratories, forensic laboratories, workplaces, sports organizations, and law enforcement, with clinical laboratories leading the market due to the high demand for accurate and reliable drug screening. Geographically, North America and Europe are the largest markets for specimen validity testing, driven by stringent regulatory requirements, while Asia-Pacific is expected to witness rapid growth due to increasing awareness and adoption of drug testing programs.

What Are the Key Drivers of Growth in the Specimen Validity Testing Market?

The growth in the specimen validity testing market is driven by several factors, including rising demand for drug testing in workplaces, law enforcement, and clinical settings, technological advancements in specimen validity testing methods and equipment, and the increasing focus on ensuring the accuracy and integrity of drug screening programs. The need to detect tampering, adulteration, substitution, and dilution in drug tests is driving the demand for specimen validity testing solutions across various sectors. Technological innovations in integrated, automated, and remote testing platforms, coupled with advancements in reagent formulations, POC devices, and digital data management, are enhancing the effectiveness, speed, and marketability of specimen validity testing, supporting market growth. The expansion of specimen validity testing applications in healthcare, sports, government, and military sectors, along with the growing emphasis on regulatory compliance, standardization, and quality assurance, is creating new opportunities for market players. Additionally, the focus on developing non-invasive, portable, and digital validity testing solutions for diverse environments is further propelling the growth of the specimen validity testing market.

SCOPE OF STUDY:

The report analyzes the Specimen Validity Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Offering (Products, Services); Type (Laboratory Testing, Rapid / POC Testing); End-Use (Workplaces, Drug Screening Laboratories, Drug Rehabilitation Centers, Pain Management Centers, Law Enforcement Agencies, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Acm Global Laboratories
  • Alfa Scientific Designs, Inc.
  • Clinical Reference Laboratory, Inc.
  • Express Diagnostics Int'l, Inc.
  • Premier Brands of America, Inc.
  • Quest Diagnostics, Inc.
  • Sciteck, Inc.
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Global Economic Update
    • Specimen Validity Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Drug Testing in Workplaces and Law Enforcement Drives Specimen Validity Testing Market Growth
    • Increasing Focus on Ensuring Accuracy and Integrity in Drug Screening Spurs Adoption of Validity Testing Solutions
    • Technological Advancements in Specimen Validity Testing Methods Propel Innovation
    • Growing Emphasis on Detecting Adulteration, Substitution, and Dilution Expands Addressable Market Opportunity
    • Emergence of Integrated, Automated, and Rapid Specimen Validity Testing Platforms Strengthens Business Case
    • Rising Use of Specimen Validity Testing in Clinical, Forensic, and Research Laboratories Accelerates Market Demand
    • Focus on Developing Point-of-Care and Remote Testing Solutions Drives Market Competitiveness
    • Growing Application of Validity Testing in Sports, Healthcare, and Addiction Treatment Fuels Market Expansion
    • Expansion of Specimen Validity Testing in Government, Military, and Immigration Sectors Spurs Market Potential
    • Shift Towards Digital, Non-Invasive, and Portable Validity Testing Technologies Expands Market Opportunities
    • Challenges in Addressing Evolving Drug Use Trends, New Psychoactive Substances, and Cheating Tactics Create Market Barriers
    • Increasing Emphasis on Standardization, Certification, and Quality Assurance in Validity Testing Creates New Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Specimen Validity Testing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Specimen Validity Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Specimen Validity Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Specimen Validity Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Laboratory Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Laboratory Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Laboratory Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Rapid / POC Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Rapid / POC Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Rapid / POC Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Workplaces by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Workplaces by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Workplaces by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Drug Rehabilitation Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Drug Rehabilitation Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Drug Rehabilitation Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Drug Screening Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Drug Screening Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Drug Screening Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Pain Management Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Pain Management Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Pain Management Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Law Enforcement Agencies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Law Enforcement Agencies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Law Enforcement Agencies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Specimen Validity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Specimen Validity Testing by Offering - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Specimen Validity Testing by Offering - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Specimen Validity Testing by Offering - Percentage Breakdown of Value Sales for Products and Services for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid / POC Testing for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Specimen Validity Testing by Offering - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Specimen Validity Testing by Offering - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Specimen Validity Testing by Offering - Percentage Breakdown of Value Sales for Products and Services for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid / POC Testing for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Specimen Validity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Specimen Validity Testing by Offering - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Specimen Validity Testing by Offering - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Specimen Validity Testing by Offering - Percentage Breakdown of Value Sales for Products and Services for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid / POC Testing for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Specimen Validity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Specimen Validity Testing by Offering - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Specimen Validity Testing by Offering - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Specimen Validity Testing by Offering - Percentage Breakdown of Value Sales for Products and Services for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid / POC Testing for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Specimen Validity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Specimen Validity Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Specimen Validity Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Specimen Validity Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Specimen Validity Testing by Offering - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Specimen Validity Testing by Offering - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Specimen Validity Testing by Offering - Percentage Breakdown of Value Sales for Products and Services for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid / POC Testing for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Specimen Validity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Specimen Validity Testing by Offering - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Specimen Validity Testing by Offering - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Specimen Validity Testing by Offering - Percentage Breakdown of Value Sales for Products and Services for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid / POC Testing for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Specimen Validity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Specimen Validity Testing by Offering - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Specimen Validity Testing by Offering - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Specimen Validity Testing by Offering - Percentage Breakdown of Value Sales for Products and Services for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid / POC Testing for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Specimen Validity Testing by Offering - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Specimen Validity Testing by Offering - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Specimen Validity Testing by Offering - Percentage Breakdown of Value Sales for Products and Services for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid / POC Testing for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Specimen Validity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Specimen Validity Testing by Offering - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Specimen Validity Testing by Offering - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Specimen Validity Testing by Offering - Percentage Breakdown of Value Sales for Products and Services for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid / POC Testing for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Specimen Validity Testing by Offering - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Specimen Validity Testing by Offering - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Europe 15-Year Perspective for Specimen Validity Testing by Offering - Percentage Breakdown of Value Sales for Products and Services for the Years 2015, 2025 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Europe 15-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid / POC Testing for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Europe 15-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Specimen Validity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Specimen Validity Testing by Offering - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Specimen Validity Testing by Offering - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Asia-Pacific 15-Year Perspective for Specimen Validity Testing by Offering - Percentage Breakdown of Value Sales for Products and Services for the Years 2015, 2025 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Asia-Pacific 15-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid / POC Testing for the Years 2015, 2025 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Asia-Pacific 15-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Specimen Validity Testing by Offering - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Specimen Validity Testing by Offering - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of World 15-Year Perspective for Specimen Validity Testing by Offering - Percentage Breakdown of Value Sales for Products and Services for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of World 15-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid / POC Testing for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of World 15-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제